[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"mvm-fgr\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:mvm-fgr":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":16,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100524133",false,"NCT06104748","A Cohort of Maternal Vascular Malperfusion-related FGR (CoMVMFGR)","Inclusion Criteria:\n\n1.Singleton pregnancy 2. diagnosed as FGR according the delphi consensus:\n\n1. Early-onset FGR(\\\u003C32 weeks) Estimated fetal weight (EFW) or abdominal circumference (AC) \\\u003C 3rd; or EFW or AC \\\u003C 10th, combined with abnormal doppler, including uterine artery pulsatility index(UtA PI) \\>95th percentile, umbilical artery pulsatility index(UA PI) \\>95th percentile； or umbilical artery absent end-diastolic flow (UA-AEDF) or umbilical artery reversed end-diastolic flow(UA-REDF).\n2. Late-onset FGR(≥32 weeks) Estimated fetal weight (EFW) or abdominal circumference (AC) \\\u003C 3rd; or \\>2 of the following 3 criteria:\n\n   * EFW or AC \\\u003C10th percentile\n   * EFW or AC crossing percentiles\\>2 quartiles on growth percentiles\n   * CPR \\\u003C5th percentile or UA-Pl\\>95th percentile 3.provision of signed written informed consent.\n\nExclusion Criteria:\n\n* Fetus with definitive genetic disorders related to FGR, fetus with confirmed intrauterine infection (CMV, syphilis and etc.), fetus with structural anomalies\n* Incomplete information or absence of informed consent","FEMALE","18 Years","45 Years",{"count":18,"type":19},500,"ESTIMATED","2 Years","OBSERVATIONAL","Based on a precise diagnostic standard process, through a multicenter study, we will establish a cohort focusing on placenta-mediated fetal growth restriction (FGR). Long-term follow-up will be conducted to seek predictive indicators for short-term and long-term adverse outcomes of maternal vascular malperfusion-related FGR (MVM-FGR).",[24],"MVM-FGR",[26,27,28,29,30],"FGR","maternal vascular malperfusion","Doppler","placenta","etiologies","RECRUITING","2024-06-06",{"date":34,"type":35},"2024-06-07","ACTUAL",{"date":37,"type":35},"2023-08-10",{"date":39,"type":19},"2025-12-30",{"name":41,"class":42},"Shanghai First Maternity and Infant Hospital","OTHER",""]